News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Genetown
PurMinds NeuroPharma Announces PUR501 as Lead Candidate Novel Non-Hallucinogenic Neuroplastogen
May 30, 2024
·
4 min read
Business
UFC and Aires Tech Announce Multi-Year Global Marketing Partnership
May 30, 2024
·
9 min read
Preveceutical Announces First Tranche Closing of Private Placement
May 30, 2024
·
5 min read
Nextleaf Solutions Reports Record Revenue $3.4 Million in Second Quarter 2024 Financial Results
May 29, 2024
·
8 min read
ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial
May 29, 2024
·
5 min read
Deals
Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation
May 29, 2024
·
3 min read
American Aires Announces Q1 2024 Results with Strong 37% YoY Sales Growth Despite Traditionally Soft Q1 Consumer Spending
May 28, 2024
·
9 min read
Resverlogix Announces Updated Annual and Special Meeting of Shareholders
May 28, 2024
·
3 min read
BioMidwest
Kraig Biocraft Laboratories Shares Update on Dragon Silk Production Utilizing the BAM-1 Platform
May 28, 2024
·
3 min read
Genetown
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio’s Lead Compound PH-762
May 28, 2024
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us